A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial malignant suppressor protein is frequently disabled in many kinds of cancer, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research